Ras Oncogenes and Phenotypic Staging in N-Methylnitrosourea- and ϒ-Irradiation-induced Thymic Lymphomas in C57BL/6J Mice

Cancer Research

Volumn 48, Issue 19, 1988, Pages 5514-5521

  Newcomb, Elizabeth W ^a   Steinberg, Jacob J ^a,b   Pellicer, Angel ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLNITROSOUREA;

ANIMAL CELL; ANIMAL EXPERIMENT; CARCINOGENESIS; GAMMA RADIATION; HISTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE RAS; PHENOTYPE; PRIORITY JOURNAL; THYMUS LYMPHOMA;

ANIMAL; DNA, NEOPLASM; FEMALE; GENES, RAS; LYMPHOMA; METHYLNITROSOUREA; MICE; MICE, INBRED C57BL; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES; THYMUS NEOPLASMS;

EID: 0023691697     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Quintanilla, M., Brown, K., Ramsden, M., and Balmain, A. Carcinogen specific mutation and amplification of the Ha-ras during mouse skin carcinogenesis. Nature (Lond.), 322: 78-80, 1986.
2. Sukumar, S., Notario, V., Martin-Zanca, D., and Barbacid, M. Induction of mammary carcinomas in rats, by nitromethylurea involves malignant activation of H-ras 1 locus by single point mutation. Nature (Lond.), 306: 658-661, 1983.
3. Reynolds, S. H., Stowers, S. J., Patterson, R. M., Maronpot, R. R., Aaronson, S. A., and Anderson, M. W. Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment. Science (Wash. DC), 237: 1309-1316, 1987.
4. Kaplan, H. S., and Brown, M. B. A quantitative dose-response study of lymphoid-tumor development in irradiated C57 black mice. J. Natl. Cancer Inst., 13: 185-208, 1952.
5. Joshi, V. V., and Frei, J. V. Gross and microscopic changes in the lymphoreticular system during genesis of malignant lymphoma induced by a single injection of methylnitrosourea in adult mice. J. Natl. Cancer Inst., 44: 379-387, 1970.
6. Guerrero, I., Calzada, P., Mayer, A., and Pellicer, A. A molecular approach to leukemogenesis: Mouse lymphomas contain an activated c-ras oncogene. Proc. Natl. Acad. Sci. USA, 81: 202-205, 1984.
7. Guerrero, I., and Pellicer, A. Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutation Res., 185: 293-308, 1987.
8. Diamond, L. E., Guerrero, I., and Pellicer, A. Concomitant K- and N-ras gene point mutations in clonal murine lymphomas. Mol. Cell. Biol., 8: 2233-2236, 1988.
9. Frei, J. V., and Lawley, P. D. Thymomas induced by simple alkylating agents in C57BL/Cbi mice: Kinetics of the dose response. J. Natl. Cancer Inst., 64: 845-856, 1980.
10. Ceredig, R., Lowenthal, J. W., Nabholz, M., and MacDonald, H. R. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature (Lond.), 314: 98-100, 1985.
11. Fink, P. J., Gallatin, W. M., Reichert, R. A., Butcher, E. C., and Weissman, I. L. Homing receptor-bearing thymocytes, and immunocompetent cortical subpopulation. Nature (Lond.), 313: 233-235, 1985.
12. Souyri, M. and Fleissner, E. Identification by transfection of transforming sequences in DNA of human T-cell leukemias. Proc. Natl. Acad. Sci. USA, 80: 6676-6679, 1983.
13. Graham, F. L., and Van der Eb, J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1973.
14. Wigler, M., Pellicer, A., Silverstein, S., Axel, R., Urlaub, G., and Chasin, L. Transformation of the aprt locus in mammalian cells. Proc. Natl. Acad. Sci. USA, 76: 1373-1376, 1979.
15. Guerrero, I., Wong, H., Pellicer, A., Burstein, D. Activated N-ras gene induces neuronal differentiation of PC-12 rat pheochromocytoma cells. J. Cell. Physiol., 129: 71-76, 1986.
16. Hidaka, K., An, G., Ip, P., Kuwana, M., and Siminovitch, L. Amphotericin B enhances efficiency of DNA-mediated gene transfer in mammalian cells. Somat. Cell Mol. Genet., 11: 109-115, 1985.
17. Hanna, N. Nude mice as recipients for syngeneic, allogeneic and xenogenic neoplasms. In: I. J. Fidler and R. J. White (eds.). Design of Models for Testing Cancer Therapeutic Agents, pp. 165-174, New York: Van Nostrand Reinhold, 1982.
18. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503-517, 1975.
19. Ellis, R. W., Defeo, D., Shih, T. Y., Gonda, M. A., Young, H. A., Tsuchida, N., Lowy, D. R., and Scolnick, E. M. The p21 src genes of Harvey and Kirsten Sarcoma viruses originate from divergent members of a family of normal vertebrate genes. Nature (Lond.), 292: 506-511, 1981.
20. Ellis, R. W., Defeo, D., Maryak, J. M., Young, H. A., Shih, T. Y., Chang, E. H., Lowy, D. R., and Scolnick, E. M. Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus. J. Virol., 36: 408-420, 1980.
21. Guerrero, I., Villasante, A., Diamond, L., Berman, J. W., Newcomb, E. W., Steinberg, J. J., Lake, R., and Pellicer, A. Oncogene activation and surface markers in mouse lymphomas induced by radiation and nitrosomethylurea. Leuk. Res., 10: 851-858, 1986.
22. Kidd, V. J., Wallace, R. B., Itakura, K., and Woo, S. L. C. α1-antitrypsin deficiency detection by analysis of the mutation in the gene. Nature (Lond.), 504: 230-234, 1983.
23. Valenzuela, D. M., and Groffen, J. Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene. Nucleic Acids Res., 14: 843-852, 1986.
24. Scott, M. L., Feinberg, M. B., Fry, K. E., Percy, D. E., and Lieberman, M. Patterns of thymocyte differentiation markers on virus and radiation induced lymphoma of C57BL/Ka mice. Int. J. Radiat. Oncol. Biol. Phys., 11: 71-78, 1985.
25. Diamantstein, T., Osawa, H., Graf, L., and Schirrmacher, V. Studies on the interleukin 2 receptor expression and IL-2 production by murine T cell lymphomas. Br. J. Cancer, 51: 23-30, 1985.
26. Reichert, R. A., Gallatin, W. M., Butcher, E. C., and Weissman, I. L. A homing receptor-bearing cortical thymocyte subset: Implications for thymus cell migration and the nature of cortisone-resistant thymocytes. Cell, 38: 89-99, 1984.
27. Takas, L., Osawa, H., and Diamantstein, T. Detection and localization by the monoclonal anti-interleukin 2 receptor antibody AMT-13 of IL 2 receptor-bearing cells in the developing thymus of the mouse embryo and in the thymus of cortisone treated mice. Eur. J. Immunol., 14: 1152-1156, 1984.
28. Scollay, R., and Shortman, K. Thymocyte subpopulations: An experimental review, including flow cytometric cross-correlations between the major murine thymocyte markers. Thymus, 5: 245-295, 1983.
29. Stocken, E., and Old, L. J. Preleukemic expression of TL antigens in X-irradiated C57BL/6 mice. J. Exp. Med., 146: 271-276, 1977.
30. Boyse, E. A., and Old, L. J. Some aspects of normal and abnormal cell surface genetics. Ann. Rev. Genet., 3: 269-290, 1969.
31. Chazan, R., and Haran-Ghera, N. The role of thymus subpopulations in “T” leukemia development. Cell. Immunol., 23: 356-375, 1976.
32. Siegler, R., and Rich, M. A. Pathogenesis of murine leukemia. Natl. Cancer Inst. Monogr., 22: 525-540, 1966.
33. Fasano, O., Birnbaum, D., Edlund, L., Fogh, J., and Wigler, M. New human transforming genes detected by a tumorigenicity assay. Mol. Cell. Biol., 4: 1695-1705, 1984.
34. Tainsky, M. A., Cooper, C. S., Giovanella, B. C., and Vande Woude, G. F. An activated rasN gene detected in late but not early passage of human PA1 teratocarcinoma cells. Science (Wash. DC), 225: 643-645, 1984.
35. Bos, J. L., Toksoz, D., Marshall, C. J., Verlaan-de Vries, M., Veeneman, G. H., Van der Eb, A. J., Van Boom, J. H., Janssen, J. W. G., and Steenvoorden, A. C. M. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature (Lond.), 315: 726-730, 1985.
36. Young, D., Waitches, G., Birchmeier, C., Fasano, O., and Wigler, M. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell, 45: 711-719, 1986.
37. Guerrero, I., Villasante, A., Corees, V., and Pellicer, A. Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen. Proc. Natl. Acad. Sci. USA, 82: 7810-7814, 1985.
38. Guererro, I., Villasante, A., Corees, V., and Pellicer, A. Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation. Science (Wash. DC), 225: 1159-1162, 1984.
39. Leon, J., Kamino, H., Steinberg, J. J., and Pellicer, A. H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system. Mol. Cell. Biol., 8: 786-793, 1988.
40. Amari, N. M. B., and Meruelo, D. Murine thymomas induced by fractionated-X-irradiation have specific T-cell receptor rearrangements and characteristics associated with day-15 to -16 fetal thymocytes. Mol. Cell. Biol., 7: 4159-4168, 1987.
41. Diamond, L. E., Berman, J. W., and Pellicer, A. Differential expression of surface markers on thymic lymphomas induced by two carcinogenic agents in different mouse strains. Cell. Immunol., 107: 115-120, 1987.
42. Zarbl, H., Sukumar, S., Arthur, A. V., Martin-Zanca, D., and Barbacid, M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature (Lond.), 315: 382-385, 1985.
43. Leon, J., Guerrero, I., and Pellicer, A. Differential expression of the ras gene family in mice. Mol. Cell. Biol., 7: 1535-1540, 1987.
44. Barbacid, M. ras genes. Ann. Rev. Biochem., 56: 779-827, 1987.
45. McMorrow, L. E., Newcomb, E. W., and Pellicer, A. Identification of a specific marker chromosome early in tumor development in γ-irradiated C57BL/6J mice. Leukemia, 2: 115-119. 1988.